One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Genes and Race in Colon Cancer.
Stebbing, Justin PhD, MD 1,; Schlechter, Benjamin L. MD 2,,
doi : 10.1200/JCO.23.02094
Volume 42(4) pgs. 369-486 February 1, 2024
Neoadjuvant Immunotherapy in Gastroesophageal Cancer: A Promising Early Signal?.
Zhu, Mojun MD 1; Yoon, Harry H. MD, MHS 1,,
doi : 10.1200/JCO.23.01982
First-Line Dual Immunotherapy, a Treatment Option in First-Line Metastatic Non-Small-Cell Lung Cancer: Are We Ready to Use It?.
Uprety, Dipesh MD 1,,; Remon, Jordi MD, PhD 2,; Peters, Solange MD, PhD 3,
doi : 10.1200/JCO.23.01524
Overall Survival With Circulating Tumor Cell Count-Driven Choice of Therapy in Advanced Breast Cancer: A Randomized Trial.
Bidard, Francois-Clement MD, PhD 1,2,,; Kiavue, Nicolas MD 1,; Jacot, William MD, PhD 3,; Bachelot, Thomas MD, PhD 4,; Dureau, Sylvain PharmD 5; Bourgeois, Hugues MD 6,; Goncalves, Anthony MD, PhD 7,; Brain, Etienne MD, PhD 1,; Ladoire, Sylvain MD, PhD 8,; Dalenc, Florence MD, PhD 9,; Gligorov, Joseph MD, PhD 10,; Teixeira, Luis MD, PhD 11,; Emile, George MD 12,; Ferrero, Jean-Marc MD, PhD 13,; Loirat, Delphine MD, PhD 1,; Cabel, Luc MD, PhD 1,2; Kadi, Amir PhD 5,; Dieras, Veronique MD 14,; Alix-Panabieres, Catherine PhD 15,16,17; Pierga, Jean-Yves MD, PhD 1,17,18,
doi : 10.1200/JCO.23.00456
Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEA.
Jagsi, Reshma MD, DPhil 1,2,,; Griffith, Kent A. MS 2; Harris, Eleanor E. MD 3,; Wright, Jean L. MD 4,; Recht, Abram MD 5,; Taghian, Alphonse G. MD, PhD 6,; Lee, Lucille MD 7,; Moran, Meena S. MD 8,; Small, William Jr MD 9,; Johnstone, Candice MD 10; Rahimi, Asal MD 11,; Freedman, Gary MD 12; Muzaffar, Mahvish MD 13,; Haffty, Bruce MD 14; Horst, Kathleen MD 15; Powell, Simon N. MD, PhD 16,; Sharp, Jody BS 2; Sabel, Michael MD 2,; Schott, Anne MD 2,; El-Tamer, Mahmoud MD 16
doi : 10.1200/JCO.23.02270
DNA Mutational Profiling in Patients With Colorectal Cancer Treated With Standard of Care Reveals Differences in Outcome and Racial Distribution of Mutations.
Innocenti, Federico MD, PhD 1,2,; Mu, Wancen PhD 3; Qu, Xueping PhD 4,; Ou, Fang-Shu PhD 5; Kabbarah, Omar PhD 5,; Blanke, Charles David MD, FACO, FASCO 6; Venook, Alan P. MD 7,; Lenz, Heinz-Josef MD, FACP 8,,; Rashid, Naim U. PhD 2,3,
doi : 10.1200/JCO.23.00825
Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial.
Lorenzen, Sylvie MD 1; Gotze, Thorsten Oliver MD 2,3,; Thuss-Patience, Peter MD 4,; Biebl, Matthias MD 5,; Homann, Nils MD 6,; Schenk, Michael MD 7; Lindig, Udo MD 8,; Heuer, Vera MD 9; Kretzschmar, Albrecht MD 10,; Goekkurt, Eray MD 11,; Haag, Georg Martin MD 12,; Riera-Knorrenschild, Jorge MD 13; Bolling, Claus MD 14; Hofheinz, Ralf-Dieter MD 15,; Zhan, Tianzuo MD 16,; Angermeier, Stefan MD 17; Ettrich, Thomas Jens MD 18,; Siebenhuener, Alexander Reinhard MD 19,20; Elshafei, Moustafa MD 21,; Bechstein, Wolf Otto MD 22,; Gaiser, Timo MD 23,; Loose, Maria PhD 2; Sookthai, Disorn MSc 2,; Kopp, Christina MSc 2,; Pauligk, Claudia PhD 2; Al-Batran, Salah-Eddin MD 2,3,,; for the AIO and SAKK Study Working Groups
doi : 10.1200/JCO.23.00975
Costs of Cancer Prevention: Physical and Psychosocial Sequelae of Risk-Reducing Total Gastrectomy.
Gallanis, Amber F. MD 1; Gamble, Lauren A. MD 1; Samaranayake, Sarah G. MS 1; Lopez, Rachael MPH, RD 2; Rhodes, Amanda PhD 1; Rajasimhan, Suraj PharmD 3; Fasaye, Grace-Ann ScM 1; Juma, Olvan MBChB 4,; Connolly, Maureen RN 5; Joyce, Stacy PA 1; Berger, Ann MD 6; Heller, Theo MD 7; Blakely, Andrew M. MD 1; Hernandez, Jonathan M. MD 1; Davis, Jeremy L. MD 1,
doi : 10.1200/JCO.23.01238
Clinical Validation of Human Papilloma Virus Circulating Tumor DNA for Early Detection of Residual Disease After Chemoradiation in Cervical Cancer.
Han, Kathy MD, MSc 1,2,,; Zou, Jinfeng PhD 1,; Zhao, Zhen MSc 1,; Baskurt, Zeynep PhD 3; Zheng, Yangqiao PhD 1; Barnes, Elizabeth MD 2,4; Croke, Jennifer MD, MHPE 1,2,; Ferguson, Sarah E. MD 1,5; Fyles, Anthony MD 1,2; Gien, Lilian MD, MSc 4,5,; Gladwish, Adam MD, MSc 2,; Lecavalier-Barsoum, Magali MD, MSc 6,; Lheureux, Stephanie MD, PhD 7,; Lukovic, Jelena MD, MPH 1,2; Mackay, Helen MD 4,7,; Marchand, Eve-Lyne MD, PhD 8; Metser, Ur MD 1,9,; Milosevic, Michael MD 1,2,; Taggar, Amandeep S. MD 2,4,; Bratman, Scott V. MD, PhD 1,2,; Leung, Eric MD, MSc 2,4
doi : 10.1200/JCO.23.00954
Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial.
Haas-Kogan, Daphne A. MD, MBA 1,; Aboian, Mariam S. MD, PhD 2,; Minturn, Jane E. MD, PhD 3,4; Leary, Sarah E.S. MD 5,6,7; Abdelbaki, Mohamed S. MD 8,; Goldman, Stewart MD 9,10,; Elster, Jennifer D. MD 11; Kraya, Adam PhD 12,; Lueder, Matthew R. MSc 12,13,; Ramakrishnan, Divya BS 2; von Reppert, Marc MD 2,14; Liu, Kevin X. MD, DPhil 1,; Rokita, Jo Lynne PhD 12; Resnick, Adam C. PhD 12; Solomon, David A. MD, PhD 15; Phillips, Joanna J. MD, PhD 15,16; Prados, Michael MD 16,17,; Molinaro, Annette M. PhD 16; Waszak, Sebastian M. PhD 18,19,20,; Mueller, Sabine MD, PhD, MAS 16,19,17,21,,
doi : 10.1200/JCO.23.01838
Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient Outcomes.
Noerenberg, Daniel MD 1,; Briest, Franziska PhD 1,; Hennch, Cornelius MD 1; Yoshida, Kenichi PhD 2,3; Hablesreiter, Raphael MSc 1; Takeuchi, Yasuhide MD 2; Ueno, Hiroo MD 2; Staiger, Annette M. PhD 4,5; Ziepert, Marita PhD 6; Asmar, Fazila MD 7; Locher, Benjamin N. MSc 1; Toth, Erika MD, PhD 8; Weber, Thomas MD 9; Amini, Rose-Marie MD, PhD 10; Klapper, Wolfram MD 11,; Bouzani, Maria MD 12,; Poeschel, Viola MD 13,; Rosenwald, Andreas MD 14; Held, Gerhard MD 13,15,; Campo, Elias MD, PhD 16,17,18,; Ishaque, Naveed PhD 19; Stamatopoulos, Kostas MD, PhD 20,21,; Kanellis, George MD 22; Anagnostopoulos, Ioannis MD 14,23,; Bullinger, Lars MD 1,24,; Goldschmidt, Neta MD 25; Zinzani, Pier Luigi MD, PhD 26,27,; Bodor, Csaba PhD 28,; Rosenquist, Richard MD, PhD 20,29,; Vassilakopoulos, Theodoros P. MD, PhD 9,30,; Ott, German MD 4; Ogawa, Seishi MD, PhD 2,31,32,; Damm, Frederik MD 1,24,,
doi : 10.1200/JCO.23.01053
CD5 Gene Signature Identifies Diffuse Large B-Cell Lymphomas Sensitive to Bruton's Tyrosine Kinase Inhibition.
Cooper, Alan BS 1; Tumuluru, Sravya PhD 2; Kissick, Kyle MD 3; Venkataraman, Girish MD 3,; Song, Joo Y. MD 4; Lytle, Andrew MD 5; Duns, Gerben PhD 6; Yu, Jovian MD, MS 1,; Kotlov, Nikita MSc 7,; Bagaev, Aleksander PhD 7,; Hodkinson, Brendan PhD 8,; Srinivasan, Srimathi PhD 9,; Smith, Sonali M. MD 1,; Scott, David W. MBChB, PhD, FRACP, FRCPA, FRCPC 6,; Steidl, Christian MD, PhD 6,; Godfrey, James K. MD 10,; Kline, Justin MD 1,2,,
doi : 10.1200/JCO.23.01574
Zanubrutinib in Waldenstrom Macroglobulinemia.
Song, Yuan-bin MD; Xu, Jing-bo MD; Gale, Robert Peter MD; Liang, Yang MD
doi : 10.1200/JCO.23.01881
Reply to Y. Song et al.
Dimopoulos, Meletios A. MD; Opat, Stephen MBBS; Treon, Steven P. MD, PhD; Tam, Constantine S. MD
doi : 10.1200/JCO.23.02162
Erratum: Improved Outcome for ALL by Prolonging Therapy for IKZF1 Deletion and Decreasing Therapy for Other Risk Groups.
doi : 10.1200/JCO.23.02556
Erratum: Trastuzumab Deruxtecan in Patients With HER2-Mutant Metastatic Non-Small-Cell Lung Cancer: Primary Results From the Randomized, Phase II DESTINY-Lung02 Trial.
doi : 10.1200/JCO.23.02574
Erratum: Re-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in Human Epidermal Growth Factor Receptor 2-Positive, Early Breast Cancer Treated With Neoadjuvant Therapy Including Anti-Human Epidermal Growth Factor Receptor 2 Therapy.
doi : 10.1200/JCO.23.02620
Erratum: Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study.
doi : 10.1200/JCO.23.02629
